Our Team

The Biomonitoring Program comprises portions of three divisions at the New Jersey Department of Health as well as the NJDEP and a number of partner organizations.

Learn More

Frequently Asked Questions

What is biomonitoring? Get answers to frequently asked questions about this program.

Learn More

Biomonitoring Commission

The Biomonitoring Commission supports the PHEL biomonitoring program throughout the course of its grant and will maintain oversight of state biomonitoring activities beyond the life of the grant.

Learn More

Biomonitoring Program

The State of New Jersey Department of Health (NJDOH) was awarded a five year biomonitoring grant from the Centers for Disease Control and Prevention (CDC) in 2014.  The purpose of the cooperative agreement is to provide the NJDOH Public Health and Environmental Laboratories (PHEL) the capability and capacity to conduct world class biomonitoring. PHEL is using a portion of the resources to acquire state-of-the-art technology that will give us the ability to test for environmental contaminants to which NJ residents could potentially be exposed.  The cooperative agreement is being used to develop three core projects that will help the State identify exposure trends.

Toxic Substances Control Act

The Toxic Substances Control Act (TSCA) publishes a list of each chemical substance that is manufactured or processed, including imports, in the United States. That list contains more than 85,000 chemicals and continues to grow.  There are many sources and routes of chemical exposure, including: air, food, water, bathing, furniture, soil, cleaning products, cosmetics and job related exposure. Some chemicals pass through the body quickly with minimal effect while others persist for a long time. Biomonitoring is the screening of blood, urine, saliva, hair, and other specimens, to help assess the exposure to or accumulation of environmental chemicals in humans.

Biomonitoring is a complement to environmental testing for chemicals and is a tool that helps public health officials in determining the root cause of exposure and how to address it.  

Though the CDC provides invaluable biomonitoring data through the National Health and Nutrition Examination Survey (NHANES) reports, it unfortunately cannot provide state-specific biomonitoring data.  NJDOH and CDC view the cooperative agreement as not only a 5-year partnership to generate NJ-specific data, but as the foundation of a permanent, self-sustaining program. NJDOH and New Jersey Department of Environmental Protection (NJDEP) leadership have worked together to establish the State of New Jersey Biomonitoring Commission to oversee and guide future biomonitoring studies. Analytical, epidemiological, environmental, academic, and exposure experts, along with community activists, have been recruited to guide the program.  The NJ Biomonitoring Program also aims to increase outreach and public awareness of the value and importance of biomonitoring to the citizens of the State of New Jersey.

Upcoming Meetings

Upcoming meeting information

2019 National Biomonitoring Meeting, Oct. 22-24, 2019, St. Paul, MN


2020 APHL Annual Meeting, June 8-11, 2020, Portland, OR


2020 ISES Annual Meeting, September 20-24, 2020, Oakland, CA


Last Reviewed: 10/2/2019